Impact of high human genetic diversity in Africa on immunogenicity and efficacy of RTS,S/AS01 vaccine

被引:0
|
作者
Stephen Tukwasibwe
Gerald Mboowa
Ivan Sserwadda
Joaniter I. Nankabirwa
Emmanuel Arinaitwe
Isaac Ssewanyana
Yoweri Taremwa
Gerald Tumusiime
Moses R. Kamya
Prasanna Jagannathan
Annettee Nakimuli
机构
[1] Infectious Diseases Research Collaboration,Infectious Diseases Institute
[2] College of Health Sciences,School of Medicine
[3] Makerere University,School of Medicine
[4] Uganda Christian University,undefined
[5] College of Health Sciences,undefined
[6] Makerere University,undefined
[7] Stanford University,undefined
来源
Immunogenetics | 2023年 / 75卷
关键词
Africa; Genetic variation; Malaria; RTS,S/AS01 vaccine;
D O I
暂无
中图分类号
学科分类号
摘要
In modern medicine, vaccination is one of the most effective public health strategies to prevent infectious diseases. Indisputably, vaccines have saved millions of lives by reducing the burden of many serious infections such as polio, tuberculosis, measles, pneumonia, and tetanus. Despite the recent recommendation by the World Health Organization (WHO) to roll out RTS,S/AS01, this malaria vaccine still faces major challenges of variability in its efficacy partly due to high genetic variation in humans and malaria parasites. Immune responses to malaria vary between individuals and populations. Human genetic variation in immune system genes is the probable cause for this heterogeneity. In this review, we will focus on human genetic factors that determine variable responses to vaccination and how variation in immune system genes affect the immunogenicity and efficacy of the RTS,S/AS01 vaccine.
引用
收藏
页码:207 / 214
页数:7
相关论文
共 50 条
  • [1] Impact of high human genetic diversity in Africa on immunogenicity and efficacy of RTS,S/AS01 vaccine
    Tukwasibwe, Stephen
    Mboowa, Gerald
    Sserwadda, Ivan
    Nankabirwa, Joaniter I.
    Arinaitwe, Emmanuel
    Ssewanyana, Isaac
    Taremwa, Yoweri
    Tumusiime, Gerald
    Kamya, Moses R.
    Jagannathan, Prasanna
    Nakimuli, Annettee
    [J]. IMMUNOGENETICS, 2023, 75 (03) : 207 - 214
  • [2] Genetic Diversity and Protective Efficacy of the RTS, S/AS01 Malaria Vaccine
    Neafsey, D. E.
    Juraska, M.
    Bedford, T.
    Benkeser, D.
    Valim, C.
    Griggs, A.
    Lievens, M.
    Abdulla, S.
    Adjei, S.
    Agbenyega, T.
    Agnandji, S. T.
    Aide, P.
    Anderson, S.
    Ansong, D.
    Aponte, J. J.
    Asante, K. P.
    Bejon, P.
    Birkett, A. J.
    Bruls, M.
    Connolly, K. M.
    D'Alessandro, U.
    Dobano, C.
    Gesase, S.
    Greenwood, B.
    Grimsby, J.
    Tinto, H.
    Hamel, M. J.
    Hoffman, I.
    Kamthunzi, P.
    Kariuki, S.
    Kremsner, P. G.
    Leach, A.
    Lell, B.
    Lennon, N. J.
    Lusingu, J.
    Marsh, K.
    Martinson, F.
    Molel, J. T.
    Moss, E. L.
    Njuguna, P.
    Ockenhouse, C. F.
    Ogutu, B. Ragama
    Otieno, W.
    Otieno, L.
    Otieno, K.
    Owusu-Agyei, S.
    Park, D. J.
    Pelle, K.
    Robbins, D.
    Russ, C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (21): : 2025 - 2037
  • [3] Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy
    Nadeem, Aroosa Younis
    Shehzad, Adeeb
    Ul Islam, Salman
    Al-Suhaimi, Ebtesam A.
    Lee, Young Sup
    [J]. VACCINES, 2022, 10 (05)
  • [4] PARASITE GENETIC DIVERSITY AND PROTECTIVE EFFICACY IN A PHASE 3 TRIAL OF THE RTS,S/AS01 MALARIA VACCINE
    Neafsey, Daniel E.
    Juraska, Michal
    Bedford, Trevor
    Benkeser, David C.
    Valim, Clarissa
    Griggs, Allison D.
    Lievens, Marc
    Agbenyega, Tsiri
    Anderson, Scott
    Bruls, Myriam
    Connolly, Kristen M.
    D'Alessandro, Umberto
    Dobano, Carlota
    Grimsby, Jonna
    Hamel, Mary J.
    Leach, Amanda
    Lennon, Niall J.
    Moss, Eli L.
    Park, Daniel J.
    Pelle, Karell G.
    Robbins, Dana
    Russ, Carsten
    Ryan, Elizabeth M.
    Sogoloff, Brian
    Volkman, Sarah K.
    Yu, Qing
    Lapierre, Didier
    Birren, Bruce W.
    Gilbert, Peter B.
    Wirth, Dyann F.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2015, 93 (04): : 112 - 112
  • [5] Assessment of the RTS,S/AS01 malaria vaccine
    Moorthy, V. S.
    Newman, R. D.
    Duclos, P.
    Okwo-Bele, J. M.
    Smith, P. G.
    [J]. LANCET INFECTIOUS DISEASES, 2013, 13 (04): : 280 - 282
  • [6] RTS,S/AS01 vaccine (Mosquirix?): an overview
    Laurens, Matthew B.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (03) : 480 - 489
  • [7] The thermostability of the RTS,S/AS01 malaria vaccine can be increased by co-lyophilizing RTS,S and AS01
    Juliette Fortpied
    Sylvie Collignon
    Nicolas Moniotte
    Frédéric Renaud
    Babak Bayat
    Dominique Lemoine
    [J]. Malaria Journal, 19
  • [8] The thermostability of the RTS,S/AS01 malaria vaccine can be increased by co-lyophilizing RTS,S and AS01
    Fortpied, Juliette
    Collignon, Sylvie
    Moniotte, Nicolas
    Renaud, Frederic
    Bayat, Babak
    Lemoine, Dominique
    [J]. MALARIA JOURNAL, 2020, 19 (01)
  • [9] Environmental modifiers of RTS,S/AS01 malaria vaccine efficacy in Lilongwe, Malawi
    Bell, Griffin J.
    Loop, Matthew S.
    Mvalo, Tisungane
    Juliano, Jonathan J.
    Mofolo, Innocent
    Kamthunzi, Portia
    Tegha, Gerald
    Lievens, Marc
    Bailey, Jeffrey
    Emch, Michael
    Hoffman, Irving
    [J]. BMC PUBLIC HEALTH, 2020, 20 (01)
  • [10] Environmental modifiers of RTS,S/AS01 malaria vaccine efficacy in Lilongwe, Malawi
    Griffin J. Bell
    Matthew S. Loop
    Tisungane Mvalo
    Jonathan J. Juliano
    Innocent Mofolo
    Portia Kamthunzi
    Gerald Tegha
    Marc Lievens
    Jeffrey Bailey
    Michael Emch
    Irving Hoffman
    [J]. BMC Public Health, 20